Novo Nordisk and Eli Lilly Shares Are Trading Higher After the Biden-Harris Administration Proposed a New Step to Expand Coverage of Anti-obesity Medications for Medicare and Medicaid Beneficiaries.
Novo Nordisk and Eli Lilly Shares Are Trading Higher After the Biden-Harris Administration Proposed a New Step to Expand Coverage of Anti-obesity Medications for Medicare and Medicaid Beneficiaries.
拜登-賀錦麗政府提出新措施，擴大醫保和醫療補助計劃受益者的抗肥胖藥物報銷範圍後，諾和諾德和禮來股票交易走高。
Novo Nordisk and Eli Lilly Shares Are Trading Higher After the Biden-Harris Administration Proposed a New Step to Expand Coverage of Anti-obesity Medications for Medicare and Medicaid Beneficiaries.
在拜登-賀錦麗政府提出擴大醫療保險和醫療補助受益人抗肥胖藥物覆蓋範圍的新措施後，諾和諾德和禮來公司的股票交易上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間